Seminars in Diagnostic Pathology
Volume 26, Issue 2 , Pages 116-121 , May 2009

Vascular and glomerular manifestations of viral hepatitis B and C: a review

  • Oyedele A. Adeyi, MD, FCAP, FRCPC

      Affiliations

    • Corresponding Author InformationAddress reprint requests and correspondence: Oyedele A. Adeyi, MD, FCAP, FRCPC, Department of Pathology, University Health Network/University of Toronto, 200 Elizabeth Street, Toronto, ON, M5G 2C4, Canada

References 

  1. Yu MC, Yuan JM, Govindarajan S, et al. Epidemiology of hepatocellular carcinoma. Can J Gastroenterol. 2000;14:703–709
  2. Lavanchy D. Hepatitis B virus epidemiology, disease burden, treatment, and current and emerging prevention and control measures. J Viral Hepat. 2004;11:97–107
  3. Global surveillance and control of hepatitis C (Report of a WHO consultation organized in collaboration with the viral hepatitis Prevention Board, Antwerp, Belgium). J Viral Hepat. 1999;6:35–47
  4. Mayo MJ. Extrahepatic manifestations of hepatitis C infection. Am J Med Sci. 2003;325:135–148
  5. Pyrsopoulos NT, Reddy KR. Extrahepatic manifestations of chronic viral hepatitis. Curr Gastroenterol Rep. 2001;3:71–78
  6. Cacoub P, Saadoun D, Bourliere M, et al. Hepatitis B virus genotypes and extrahepatic manifestations. J Hepatol. 2005;43:764–770
  7. Cacoub P, Poynard T, Ghillani P, et al. Extrahepatic manifestations of chronic hepatitis C (MULTIVIRC Group. Multidepartment virus C). Arthritis Rheum. 1999;42:2204–2212
  8. Musset L, Diemert MC, Taibi F, et al. Characterization of cryoglobulins by immunoblotting. Clin Chem. 1992;38:798–802
  9. Mascia MT, Ferrari D, Campioli D, et al. Non HCV-related mixed cryoglobulinemia. Dig Liver Dis. 2007;39:S61–S64
  10. Levo Y, Gorevic PD, Kassab HJ, et al. Association between hepatitis B virus and essential mixed cryoglobulinemia. N Engl J Med. 1977;296:1501–1504
  11. Ferri C, Sebastiani M, Giuggioli D, et al. Mixed cryoglobulinemia: Demographic, clinical, and serologic features and survival in 231 patients. Semin Arthritis Rheum. 2004;33:355–374
  12. Ferri C, Giuggioli D, Cazzato M, et al. HCV-related cryoglobulinemic vasculitis: An update on its etiopathogenesis and therapeutic strategies. Clin Exp Rheumatol. 2003;21:S78–S84
  13. Zignego AL, Ferri C, Giannelli F, et al. Prevalence of Bcl-2 rearrangement in patients with hepatitis C virus-related mixed cryoglobulinemia with or without B-cell lymphomas. Ann Intern Med. 2002;137:571–580
  14. Fornasieri A, Li M, Armelloni S, et al. Glomerulonephritis induced by human IgMK-IgG cryoglobulins in mice. Lab Invest. 1993;69:531–540
  15. Ferri C. Mixed cryoglobulinemia. Orphanet J Rare Dis. 2008;3:25
  16. Ahmed MS, Wong CF, Shawki H, et al. Rapidly deteriorating renal function with membranoproliferative glomerulonephritis type 1 associated with hepatitis C treated successfully with steroids and antiviral therapy: A case report and review of literature. Clin Nephrol. 2008;69:298–301
  17. Janssen HL, van Zonneveld M, van Nunen AB, et al. Polyarteritis nodosa associated with hepatitis B virus infection (The role of antiviral treatment and mutations in the hepatitis B virus genome). Eur J Gastroenterol Hepatol. 2004;16:801–807
  18. Guillevin L, Lhote F, Cohen P, et al. Polyarteritis nodosa related to hepatitis B virus (A prospective study with long-term observation of 41 patients). Medicine (Baltimore). 1995;74:238–253
  19. Guillevin L, Mahr A, Callard P, et al. Hepatitis B virus-associated polyarteritis nodosa: Clinical characteristics, outcome, and impact of treatment in 115 patients. Medicine (Baltimore). 2005;84:313–322
  20. Scott DG, Bacon PA, Elliott PJ, et al. Systemic vasculitis in a district general hospital 1972-1980: Clinical and laboratory features, classification and prognosis of 80 cases. Q J Med. 1982;51:292–311
  21. Mahr A, Guillevin L, Poissonnet M, et al. Prevalences of polyarteritis nodosa, microscopic polyangiitis, Wegener's granulomatosis, and Churg-Strauss syndrome in a French urban multiethnic population in 2000: A capture-recapture estimate. Arthritis Rheum. 2004;51:92–99
  22. McMahon BJ, Heyward WL, Templin DW, et al. Hepatitis B-associated polyarteritis nodosa in Alaskan Eskimos: Clinical and epidemiologic features and long-term follow-up. Hepatology. 1989;9:97–101
  23. Ramos-Casals M, Jara LJ, Medina F, et al. Systemic autoimmune diseases co-existing with chronic hepatitis C virus infection (the HISPAMEC Registry): Patterns of clinical and immunological expression in 180 cases. J Intern Med. 2005;257:549–557
  24. Trepo C, Guillevin L. Polyarteritis nodosa and extrahepatic manifestations of HBV infection: The case against autoimmune intervention in pathogenesis. J Autoimmun. 2001;16:269–274
  25. Wartelle-Bladou C, Lafon J, Trepo C, et al. Successful combination therapy of polyarteritis nodosa associated with a pre-core promoter mutant hepatitis B virus infection. J Hepatol. 2001;34:774–779
  26. Guillevin L, Lhote F, Gayraud M, et al. Prognostic factors in polyarteritis nodosa and Churg-Strauss syndrome (A prospective study in 342 patients). Medicine (Baltimore). 1996;75:17–28
  27. Lightfoot RW, Michel BA, Bloch DA, et al. The American College of Rheumatology 1990 criteria for the classification of polyarteritis nodosa. Arthritis Rheum. 1990;33:1088–1093
  28. Mason A, Theal J, Bain V, et al. Hepatitis B virus replication in damaged endothelial tissues of patients with extrahepatic disease. Am J Gastroenterol. 2005;100:972–976
  29. Stokes MB. Immune complex glomerulonephritis in patients with hepatitis C. Saudi J Kidney Dis Transpl. 2000;11:396–404
  30. Johnson RJ, Couser WG. Hepatitis B infection and renal disease: Clinical, immunopathogenetic and therapeutic considerations. Kidney Int. 1990;37:663–676
  31. Prieto J, Yuste JR, Beloqui O, et al. Anticardiolipin antibodies in chronic hepatitis C: Implication of hepatitis C virus as the cause of the antiphospholipid syndrome. Hepatology. 1996;23:199–204
  32. Sene D, Piette JC, Cacoub P. Antiphospholipid antibodies, antiphospholipid syndrome and infections. Autoimmun Rev. 2008;7:272–277
  33. Watanabe T, Oono Y, Takeshita E, et al. A case of ANCA associated vasculitis induced by interferon therapy for HCV infection. Nippon Shokakibyo Gakkai Zasshi. 2008;105:1787–1793
  34. de Dios Garcia-Diaz J, Garcia-Sanchez M, Busteros JI, et al. Polyarteritis nodosa after interferon treatment for chronic hepatitis C. J Clin Virol. 2005;32:181–182
  35. Yuste JR, Prieto J. Anticardiolipin antibodies in chronic viral hepatitis. Do they have clinical consequences?. Eur J Gastroenterol Hepatol. 2003;15:717–719
  36. Zachou K, Liaskos C, Rigopoulou E, et al. Presence of high avidity anticardiolipin antibodies in patients with autoimmune cholestatic liver diseases. Clin Immunol. 2006;119:203–212
  37. Elefsiniotis IS, Diamantis ID, Dourakis SP, et al. Anticardiolipin antibodies in chronic hepatitis B and chronic hepatitis D infection, and hepatitis B-related hepatocellular carcinoma. Relationship with portal vein thrombosis. Eur J Gastroenterol Hepatol. 2003;15:721–726
  38. Matsumori A. Role of hepatitis C virus in cardiomyopathies. Ernst Schering Res Found Workshop. 2006;55:99–120
  39. Sanchez MJ, Bergasa NV. Hepatitis C associated cardiomyopathy: Potential pathogenic mechanisms and clinical implications. Med Sci Monit. 2008;14:RA55–RA63

PII: S0740-2570(09)00019-7

doi: 10.1053/j.semdp.2009.08.003

Seminars in Diagnostic Pathology
Volume 26, Issue 2 , Pages 116-121 , May 2009

Article Tools

* Image Usage & Resolution